Nihon Kohden (OTCMKTS:NHNKY) Sets New 1-Year Low – Here’s What Happened

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $8.93 and last traded at $8.93, with a volume of 11398 shares. The stock had previously closed at $9.1024.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy”.

Nihon Kohden Trading Down 1.5%

The company has a fifty day moving average of $9.76 and a 200-day moving average of $10.72. The company has a market capitalization of $1.57 billion, a price-to-earnings ratio of 18.04 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, February 5th. The company reported $0.16 earnings per share for the quarter. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%. The business had revenue of $362.86 million for the quarter. As a group, equities research analysts expect that Nihon Kohden Corporation will post 0.48 EPS for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.